The Maharashtra Food and Drug Administration (FDA) has proposed to the state government the establishment of a quality assurance portal to ensure that safe and effective medicines are provided to consumers and patients...
The 8th international conference on Indian pharmaceuticals and medical devices was successfully concluded today by the Federation of Indian Chambers of Commerce and Industry (FICCI). The conference, which was inaugurated by Union Ministers of....
Sun Pharma currently holds 78.48 percent stake in Taro. The company had initiated similar plans a decade earlier as well.The all-cash deal proposes to value Taro at $38 per share, which is a 41.5 percent premium over the stock's average closing ...
India's pharmaceutical industry is robust and resilient and that is exactly why it could not only meet its own demand during the pandemic but also was in a position to supply medicines to 150 countries, Union Minister of Health and Family Welfare...
The diagnostics industry is increasingly being shaped by innovative business models such as franchising, subscription-based services, and digital platforms.
As per AstraZeneca this week, a late-stage trial in patients with advanced or recurrent endometrial cancer found that combining its cancer drugs Imfinzi and Lynparza with platinum-based chemotherapy produced positive results...
The Catalyst Management Services (CMS) concluded a two-day meeting to bring together partners and government stakeholders of a joint engagement on leveraging lessons learned from achieving Covid-19 vaccine equity to strengthen Asian health systems...
Biocon Biologics, based in India, finished the fiscal year ended March 31 with revenue approaching $1 billion, according to the company's CEO, thanks to robust sales in the United States and Europe from the biosimilars business it acquired ...
Evercare Group and Indus Health Plus have announced a 12-month exclusive partnership to provide Indus Health Plus beneficiaries with extended care at Evercare facilities. Evercare, a healthcare service provider with facilities in India,...
Piramal Pharma shares rose 13.5 percent in early trade on May 25, as investors cheered the drugmaker's strong earnings recovery in the fiscal quarter ended March 31, 2023. During the fourth quarter of FY23, the company achieved its highest margins...
, CDSCO.jpg)
